{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T17:11:37Z","timestamp":1779210697359,"version":"3.51.4"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T00:00:00Z","timestamp":1775260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"vor","delay-in-days":45,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pharmacol Toxicol"],"DOI":"10.1186\/s40360-026-01130-2","type":"journal-article","created":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T11:24:37Z","timestamp":1775301877000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Thyroid hormone changes after tumor necrosis factor inhibitor therapy in euthyroid patients with rheumatic diseases"],"prefix":"10.1186","volume":"27","author":[{"given":"Bayram","family":"Kizilkaya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filiz","family":"Mercantepe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jelena","family":"Vekic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osman","family":"Cure","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksandra","family":"Klisic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,4]]},"reference":[{"key":"1130_CR1","doi-asserted-by":"publisher","DOI":"10.1007\/s12011-024-04239-9","author":"E Ciftel","year":"2024","unstructured":"Ciftel E, Mercantepe F, Mercantepe T, Akyildiz K, Yilmaz A, Ciftel S. Comparative Analysis of Epigallocatechin-3-Gallate and TNF-Alpha Inhibitors in Mitigating Cisplatin-Induced Pancreatic Damage Through Oxidative Stress and Apoptosis Pathways. Biol Trace Elem Res. 2024. https:\/\/doi.org\/10.1007\/s12011-024-04239-9.","journal-title":"Biol Trace Elem Res"},{"key":"1130_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13075-023-03251-z","volume":"26","author":"T Fujii","year":"2024","unstructured":"Fujii T, Murata K, Onizawa H, Onishi A, Tanaka M, Murakami K, Nishitani K, Furu M, Watanabe R, Hashimoto M, et al. Management and Treatment Outcomes of Rheumatoid Arthritis in the Era of Biologic and Targeted Synthetic Therapies: Evaluation of 10-Year Data from the KURAMA Cohort. Arthritis Res Ther. 2024;26:1\u201310. https:\/\/doi.org\/10.1186\/s13075-023-03251-z.","journal-title":"Arthritis Res Ther"},{"key":"1130_CR3","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1093\/rheumatology\/keq031","volume":"49","author":"T Horiuchi","year":"2010","unstructured":"Horiuchi T, Mitoma H, Harashima SI, Tsukamoto H, Shimoda T. Transmembrane TNF-\u03b1: Structure, Function and Interaction with Anti-TNF Agents. Rheumatology. 2010;49:1215\u201328. https:\/\/doi.org\/10.1093\/rheumatology\/keq031.","journal-title":"Rheumatology"},{"key":"1130_CR4","doi-asserted-by":"publisher","first-page":"8","DOI":"10.7759\/cureus.42783","volume":"15","author":"A Pawar","year":"2023","unstructured":"Pawar A, Joshi P, Singhai A. An Assessment of Thyroid Dysfunction and Related Parameters in Patients With Systemic Autoimmune Disorders. Cureus. 2023;15:8\u201313. https:\/\/doi.org\/10.7759\/cureus.42783.","journal-title":"Cureus"},{"key":"1130_CR5","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1007\/s10067-013-2466-1","volume":"33","author":"H Emmungil","year":"2014","unstructured":"Emmungil H, Erdogan M, Kalfa M, Karabulut G, Kocanaogullar\u0131 H, Inal V, Aksu K, Oksel F, Kabasakal Y, Keser G. Autoimmune Thyroid Disease in Ankylosing Spondylitis. Clin Rheumatol. 2014;33:955\u201361. https:\/\/doi.org\/10.1007\/s10067-013-2466-1.","journal-title":"Clin Rheumatol"},{"key":"1130_CR6","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s12020-015-0671-1","volume":"50","author":"U Feldt-Rasmussen","year":"2015","unstructured":"Feldt-Rasmussen U. Increased Risk of Thyroid Autoimmunity in Rheumatoid Arthritis. Endocrine. 2015;50:4\u20135. https:\/\/doi.org\/10.1007\/s12020-015-0671-1.","journal-title":"Endocrine"},{"key":"1130_CR7","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s12020-015-0533-x","volume":"50","author":"XF Pan","year":"2015","unstructured":"Pan XF, Gu JQ, Shan ZY. Increased Risk of Thyroid Autoimmunity in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis. Endocrine. 2015;50:79\u201386. https:\/\/doi.org\/10.1007\/s12020-015-0533-x.","journal-title":"Endocrine"},{"key":"1130_CR8","doi-asserted-by":"publisher","first-page":"247","DOI":"10.3899\/jrheum.100488","volume":"38","author":"HG Raterman","year":"2011","unstructured":"Raterman HG, Jamnitski A, Lems WF, Voskuyl AE, Dijkmans BAC, Bos WH, Simsek S, Van De Lips P, De Koning, M.H.M T, et al. Improvement of Thyroid Function in Hypothyroid Patients with Rheumatoid Arthritis after 6 Months of Adalimumab Treatment: A Pilot Study. J Rheumatol. 2011;38:247\u201351. https:\/\/doi.org\/10.3899\/jrheum.100488.","journal-title":"J Rheumatol"},{"key":"1130_CR9","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1007\/s10067-024-06888-6","volume":"43","author":"A Lichtiger","year":"2024","unstructured":"Lichtiger A, Fadaei G, Tagoe CE. Autoimmune Thyroid Disease and Rheumatoid Arthritis: Where the Twain Meet. Clin Rheumatol. 2024;43:895\u2013905. https:\/\/doi.org\/10.1007\/s10067-024-06888-6.","journal-title":"Clin Rheumatol"},{"key":"1130_CR10","doi-asserted-by":"publisher","unstructured":"Zhang K, Luo Z, Wang X. The association of common autoimmune diseases with autoimmune thyroiditis: a two-sample mendelian randomization study. Front Endocrinol (Lausanne). 2024;15. https:\/\/doi.org\/10.3389\/fendo.2024.1383221.","DOI":"10.3389\/fendo.2024.1383221"},{"key":"1130_CR11","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1507\/endocrj.EJ18-0243","volume":"65","author":"SA Paschou","year":"2018","unstructured":"Paschou SA, Palioura E, Kothonas F, Myroforidis A, Loi V, Poulou A, Goumas K, Effraimidis G, Vryonidou A. The Effect of Anti-Tnf Therapy on Thyroid Function in Patients with Inflammatory Bowel Disease. Endocr J. 2018;65:1121\u20135. https:\/\/doi.org\/10.1507\/endocrj.EJ18-0243.","journal-title":"Endocr J"},{"key":"1130_CR12","doi-asserted-by":"publisher","first-page":"144","DOI":"10.5114\/pedm.2020.95618","volume":"26","author":"A Furtak","year":"2020","unstructured":"Furtak A, Wedrychowicz A, Starzyk J. Anti-Tumour Necrosis Factor \u03b1 Therapy \u2013 Does It Increase the Risk of Thyroid Disease or Protect against Its Development? Pediatr. Endocrinol Diabetes Metab. 2020;26:144\u20139. https:\/\/doi.org\/10.5114\/pedm.2020.95618.","journal-title":"Endocrinol Diabetes Metab"},{"key":"1130_CR13","doi-asserted-by":"publisher","unstructured":"Bliddal S, Borresen SW, Feldt-Rasmussen U. Thyroid autoimmunity and function after treatment with biological antirheumatic agents in rheumatoid arthritis. Front Endocrinol (Lausanne). 2017;8. https:\/\/doi.org\/10.3389\/fendo.2017.00179.","DOI":"10.3389\/fendo.2017.00179"},{"key":"1130_CR14","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s10067-008-1046-2","volume":"28","author":"CA Ca\u00f1as","year":"2009","unstructured":"Ca\u00f1as CA, Tob\u00f3n GJ, Arango LG, Guar\u00edn N. Developing of Granulomatous Thyroiditis during Etanercept Therapy. Clin Rheumatol. 2009;28:17\u20139. https:\/\/doi.org\/10.1007\/s10067-008-1046-2.","journal-title":"Clin Rheumatol"},{"key":"1130_CR15","doi-asserted-by":"publisher","first-page":"101366","DOI":"10.1016\/j.beem.2019.101366","volume":"34","author":"SM Ferrari","year":"2020","unstructured":"Ferrari SM, Fallahi P, Elia G, Ragusa F, Camastra S, Paparo SR, Giusti C, Gonnella D, Ruffilli I, Shoenfeld Y, et al. Novel Therapies for Thyroid Autoimmune Diseases: An Update. Best Pract Res Clin Endocrinol Metab. 2020;34:101366. https:\/\/doi.org\/10.1016\/j.beem.2019.101366.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"1130_CR16","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1080\/24725625.2020.1741116","volume":"5","author":"J Nakagawa","year":"2021","unstructured":"Nakagawa J, Fujikawa K, Akagi M, Nakaji K, Yasui J, Hanatani Y, Hara T, Mizokami A, Kawakami A. Subacute Thyroiditis in a Patient with Psoriatic Arthritis Switched from Secukinumab to Adalimumab: A Case Report and Literature Review. Mod Rheumatol Case Rep. 2021;5:36\u20139. https:\/\/doi.org\/10.1080\/24725625.2020.1741116.","journal-title":"Mod Rheumatol Case Rep"},{"key":"1130_CR17","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1080\/08916930701620050","volume":"41","author":"F Atzeni","year":"2008","unstructured":"Atzeni F, Doria A, Ghirardello A, Villalta D, Zampieri S, Carrabba M, Sarzi-Puttini P. Organ-Specific Autoantibodies in Patients with Rheumatoid Arthritis Treated with Adalimumab: A Prospective Long-Term Follow-Up. Autoimmunity. 2008;41:87\u201391. https:\/\/doi.org\/10.1080\/08916930701620050.","journal-title":"Autoimmunity"},{"key":"1130_CR18","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1097\/IOP.0000000000000211","volume":"30","author":"R Ayabe","year":"2014","unstructured":"Ayabe R, Rootman DB, Hwang CJ, Ben-Artzi A, Goldberg R. Adalimumab as Steroid-Sparing Treatment of Inflammatory-Stage Thyroid Eye Disease. Ophthal Plast Reconstr Surg. 2014;30:415\u20139. https:\/\/doi.org\/10.1097\/IOP.0000000000000211.","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"1130_CR19","doi-asserted-by":"publisher","first-page":"463","DOI":"10.5114\/ceji.2019.92803","volume":"44","author":"O Boskovic","year":"2019","unstructured":"Boskovic O, Medenica S, Radojevic N, Zarkovic M. Etanercept in the Treatment of Graves\u2019 Ophthalmopathy with Primary Hypothyroidism and Rheumatoid Arthritis. Cent Eur J Immunol. 2019;44:463\u20135. https:\/\/doi.org\/10.5114\/ceji.2019.92803.","journal-title":"Cent Eur J Immunol"},{"key":"1130_CR20","doi-asserted-by":"publisher","first-page":"42","DOI":"10.15386\/cjmed-813","volume":"91","author":"II Roman","year":"2018","unstructured":"Roman II, Mocan T, Orasan MS, Jianu EM, Sfrangeu CA, Orasan RI. Relationship between Etanercept and Thyroid Function in Patients with Psoriasis Vulgaris. Clujul Med. 2018;91:42\u20137. https:\/\/doi.org\/10.15386\/cjmed-813.","journal-title":"Clujul Med"},{"key":"1130_CR21","doi-asserted-by":"publisher","unstructured":"Kawashima J, Naoe H, Sasaki Y, Araki E. A rare case showing subacute thyroiditis-like symptoms with amyloid goiter after anti-tumor necrosis factor therapy. Endocrinol Diabetes Metab Case Rep. 2015;2015. https:\/\/doi.org\/10.1530\/edm-14-0117.","DOI":"10.1530\/edm-14-0117"},{"key":"1130_CR22","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1097\/IOP.0000000000002315","volume":"39","author":"NF Xavier","year":"2023","unstructured":"Xavier NF, Lucena DT, Cruz AAV. Monoclonal Antibodies for the Treatment of Graves Orbitopathy: Precision Medicine? Ophthal. Plast Reconstr Surg. 2023;39:307\u201315. https:\/\/doi.org\/10.1097\/IOP.0000000000002315.","journal-title":"Plast Reconstr Surg"},{"key":"1130_CR23","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/S0140-6736(23)02629-6","volume":"403","author":"G Emmi","year":"2024","unstructured":"Emmi G, Bettiol A, Hatemi G, Prisco D. Beh\u00e7et\u2019s Syndrome. Lancet. 2024;403:1093\u2013108. https:\/\/doi.org\/10.1016\/S0140-6736(23)02629-6.","journal-title":"Lancet"},{"key":"1130_CR24","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1093\/rheumatology\/kes279","volume":"51","author":"J Kay","year":"2012","unstructured":"Kay J, Upchurch KS. ACR\/EULAR 2010 Rheumatoid Arthritis Classification Criteria. Rheumatol (United Kingdom). 2012;51:5\u20139. https:\/\/doi.org\/10.1093\/rheumatology\/kes279.","journal-title":"Rheumatol (United Kingdom)"},{"key":"1130_CR25","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1136\/ard.2010.133645","volume":"70","author":"M Van Der Rudwaleit","year":"2011","unstructured":"Van Der Rudwaleit M, Landew\u00e9 R, Akkoc N, Brandt J, Chou CT, Dougados M, Huang F, Gu J, Kirazli Y, et al. The Assessment of SpondyloArthritis International Society Classification Criteria for Peripheral Spondyloarthritis and for Spondyloarthritis in General. Ann Rheum Dis. 2011;70:25\u201331. https:\/\/doi.org\/10.1136\/ard.2010.133645.","journal-title":"Ann Rheum Dis"},{"key":"1130_CR26","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1055\/s-0035-1548832","volume":"47","author":"RA Ajjan","year":"2015","unstructured":"Ajjan RA, Weetman AP. The Pathogenesis of Hashimoto\u2019s Thyroiditis: Further Developments in Our Understanding. Horm Metab Res. 2015;47:702\u201310. https:\/\/doi.org\/10.1055\/s-0035-1548832.","journal-title":"Horm Metab Res"},{"key":"1130_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ando.2010.03.005","author":"B Hansel","year":"2010","unstructured":"Hansel B, Bruckert E. Ann Endocrinol (Paris). 2010;71:257\u201363. https:\/\/doi.org\/10.1016\/j.ando.2010.03.005. Profil Lipidique et Risque Cardiovasculaire Chez Les Patients Atteints de Polyarthrite Rhumatoide: Influence de La Maladie et de La Th\u00e9rapeutique M\u00e9dicamenteuse."},{"key":"1130_CR28","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.3899\/jrheum.150193","volume":"42","author":"SC Heslinga","year":"2015","unstructured":"Heslinga SC, Peters MJ, Van Der Ter Wee MM, Van Sijl AM, Smulders YM, Nurmohamed MT. Reduction of Inflammation Drives Lipid Changes in Ankylosing Spondylitis. J Rheumatol. 2015;42:1842\u20135. https:\/\/doi.org\/10.3899\/jrheum.150193.","journal-title":"J Rheumatol"},{"key":"1130_CR29","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1002\/art.24492","volume":"60","author":"IC Van Eijk","year":"2009","unstructured":"Van Eijk IC, De Vries MK, Levels JHM, Peters MJL, Huizer EE, Van Der Dijkmans BAC, Van De Hazenberg BPC, Wolbink GJ, et al. Improvement of Lipid Profile Is Accompanied by Atheroprotective Alterations in High-Density Lipoprotein Composition upon Tumor Necrosis Factor Blockade: A Prospective Cohort Study in Ankylosing Spondylitis. Arthritis Rheum. 2009;60:1324\u201330. https:\/\/doi.org\/10.1002\/art.24492.","journal-title":"Arthritis Rheum"},{"key":"1130_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13075-015-0559-8","volume":"17","author":"DY Chen","year":"2015","unstructured":"Chen DY, Chen YM, Hsieh TY, Hsieh CW, Lin CC, Lan JL. Significant Effects of Biologic Therapy on Lipid Profiles and Insulin Resistance in Patients with Rheumatoid Arthritis. Arthritis Res Ther. 2015;17:1\u201313. https:\/\/doi.org\/10.1186\/s13075-015-0559-8.","journal-title":"Arthritis Res Ther"},{"key":"1130_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0090757","volume":"9","author":"KW Yeh","year":"2014","unstructured":"Yeh KW, Lee CM, Chang CJ, Lin YJ, Huang JL. Lipid Profiles Alter from Pro-Atherogenic into Less Atherogenic and Proinflammatory in Juvenile Idiopathic Arthritis Patients Responding to Anti TNF-\u03b1 Treatment. PLoS ONE. 2014;9:1\u20137. https:\/\/doi.org\/10.1371\/journal.pone.0090757.","journal-title":"PLoS ONE"},{"key":"1130_CR32","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1007\/s00380-022-02114-y","volume":"37","author":"GV Papamichail","year":"2022","unstructured":"Papamichail GV, Markatseli TE, Georgiadis AN, Xydis VG, Milionis H, Drosos AA, Voulgari PV. The Effects of Biologic Agents on Cardiovascular Risk Factors and Atherosclerosis in Rheumatoid Arthritis Patients: A Prospective Observational Study. Heart Vessels. 2022;37:2128\u201336. https:\/\/doi.org\/10.1007\/s00380-022-02114-y.","journal-title":"Heart Vessels"},{"key":"1130_CR33","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1080\/14712598.2020.1704727","volume":"20","author":"F Atzeni","year":"2020","unstructured":"Atzeni F, Nucera V, Galloway J, Zolt\u00e1n S, Nurmohamed M. Cardiovascular Risk in Ankylosing Spondylitis and the Effect of Anti-TNF Drugs: A Narrative Review. Expert Opin Biol Ther. 2020;20:517\u201324. https:\/\/doi.org\/10.1080\/14712598.2020.1704727.","journal-title":"Expert Opin Biol Ther"},{"key":"1130_CR34","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s10238-014-0323-4","volume":"15","author":"N Maruotti","year":"2015","unstructured":"Maruotti N, d\u2019Onofrio F, Cantatore FP. Metabolic Syndrome and Chronic Arthritis: Effects of Anti-TNF-\u03b1 Therapy. Clin Exp Med. 2015;15:433\u20138. https:\/\/doi.org\/10.1007\/s10238-014-0323-4.","journal-title":"Clin Exp Med"},{"key":"1130_CR35","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jbspin.2007.04.014","volume":"75","author":"M Soubrier","year":"2008","unstructured":"Soubrier M, Jouanel P, Mathieu S, Poujol D, Claus D, Dubost JJ, Ristori JM. Effects of Anti-Tumor Necrosis Factor Therapy on Lipid Profile in Patients with Rheumatoid Arthritis. Jt Bone Spine. 2008;75:22\u20134. https:\/\/doi.org\/10.1016\/j.jbspin.2007.04.014.","journal-title":"Jt Bone Spine"},{"key":"1130_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1824-7288-39-64","volume":"39","author":"AN Olivieri","year":"2013","unstructured":"Olivieri AN, Iafusco D, Mellos A, Zanfardino A, Mauro A, Granato C, Gicchino MF, Prisco F, Perrone L. Refractory Rheumatoid Factor Positive Polyarthritis in a Female Adolescent Already Suffering from Type 1 Diabetes Mellitus and Hashimoto\u2019s Thyroiditis Successfully Treated with Etanercept. Ital J Pediatr. 2013;39:1. https:\/\/doi.org\/10.1186\/1824-7288-39-64.","journal-title":"Ital J Pediatr"},{"key":"1130_CR37","doi-asserted-by":"publisher","first-page":"R141","DOI":"10.1186\/ar3874","volume":"14","author":"I Stagakis","year":"2012","unstructured":"Stagakis I, Bertsias G, Karvounaris S, Kavousanaki M, Virla D, Raptopoulou A, Kardassis D, Boumpas DT, Sidiropoulos PI. Anti-Tumor Necrosis Factor Therapy Improves Insulin Resistance, Beta Cell Function and Insulin Signaling in Active Rheumatoid Arthritis Patients with High Insulin Resistance. Arthritis Res Ther. 2012;14:R141. https:\/\/doi.org\/10.1186\/ar3874.","journal-title":"Arthritis Res Ther"},{"key":"1130_CR38","first-page":"850","volume":"30","author":"JA Miranda-Filloy","year":"2012","unstructured":"Miranda-Filloy JA, Llorca J, Carnero-L\u00f3pez B, Gonz\u00e1lez-Juanatey C, Blanco R, Gonz\u00e1lez-Gay MA. TNF-Alpha Antagonist Therapy Improves Insulin Sensitivity: In Non-Diabetic Ankylosing Spondylitis Patients. Clin Exp Rheumatol. 2012;30:850\u20135.","journal-title":"Clin Exp Rheumatol"},{"key":"1130_CR39","doi-asserted-by":"publisher","unstructured":"Paschou P S.A., Kothonas F, Lafkas A, Myroforidis A, Loi V, Terzi T, Karagianni O, Poulou A, Goumas K, Vryonidou A. Favorable Effect of Anti-TNF Therapy on Insulin Sensitivity in Nonobese, Nondiabetic Patients with Inflammatory Bowel Disease. Int J Endocrinol. 2018;2018:10\u20134. https:\/\/doi.org\/10.1155\/2018\/6712901.","DOI":"10.1155\/2018\/6712901"},{"key":"1130_CR40","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1080\/03007995.2019.1654988","volume":"35","author":"A Corrado","year":"2019","unstructured":"Corrado A, Colia R, Rotondo C, Sanpaolo E, Cantatore FP. Changes in Serum Adipokines Profile and Insulin Resistance in Patients with Rheumatoid Arthritis Treated with Anti-TNF-\u03b1. Curr Med Res Opin. 2019;35:2197\u2013205. https:\/\/doi.org\/10.1080\/03007995.2019.1654988.","journal-title":"Curr Med Res Opin"},{"key":"1130_CR41","doi-asserted-by":"publisher","unstructured":"Gupta-Ganguli M, Cox K, Means B, Gerling I, Solomon SS. Does therapy with Anti-TNF-\u03b1 improve glucose tolerance and control in patients with type 2 diabetes? diabetes care. 2011;34:2011. https:\/\/doi.org\/10.2337\/dc10-1334.","DOI":"10.2337\/dc10-1334"},{"key":"1130_CR42","doi-asserted-by":"publisher","first-page":"3747","DOI":"10.1007\/s10067-022-06330-9","volume":"41","author":"IAP Swart","year":"2022","unstructured":"Swart IAP, Visman IM, van der Heslinga M, van Denderen JC, Nurmohamed MT. The Effect of Anti-TNF on Renal Function in Patients with Ankylosing Spondylitis: A Prospective Cohort Study. Clin Rheumatol. 2022;41:3747\u201352. https:\/\/doi.org\/10.1007\/s10067-022-06330-9.","journal-title":"Clin Rheumatol"},{"key":"1130_CR43","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1007\/s40259-022-00547-5","volume":"36","author":"CB Chen","year":"2022","unstructured":"Chen CB, Huang YT, Hsiao CC, Chang SH, Chi CC. Real-World Effects of Biologics on Renal Function in Psoriatic Patients: A Retrospective Study. BioDrugs. 2022;36:657\u201366. https:\/\/doi.org\/10.1007\/s40259-022-00547-5.","journal-title":"BioDrugs"},{"key":"1130_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1677\/JOE-09-0412","volume":"205","author":"MH Warner","year":"2010","unstructured":"Warner MH, Beckett GJ. Mechanisms behind the Non-Thyroidal Illness Syndrome: An Update. J Endocrinol. 2010;205:1\u201313. https:\/\/doi.org\/10.1677\/JOE-09-0412.","journal-title":"J Endocrinol"},{"key":"1130_CR45","doi-asserted-by":"publisher","first-page":"R67","DOI":"10.1530\/JOE-16-0462","volume":"232","author":"AH n der Spek","year":"2017","unstructured":"n der Spek AH, Fliers E, Boelen A. Thyroid Hormone Metabolism in Innate Immune Cells. J Endocrinol. 2017;232:R67\u201381. https:\/\/doi.org\/10.1530\/JOE-16-0462.","journal-title":"J Endocrinol"},{"key":"1130_CR46","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1210\/er.2011-0007","volume":"32","author":"A Boelen","year":"2011","unstructured":"Boelen A, Kwakkel J, Fliers E. Beyond Low Plasma T 3: Local Thyroid Hormone Metabolism during Inflammation and Infection. Endocr Rev. 2011;32:670\u201393. https:\/\/doi.org\/10.1210\/er.2011-0007.","journal-title":"Endocr Rev"},{"key":"1130_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5492\/wjccm.v14.i3.102577","volume":"14","author":"C Savvidis","year":"2025","unstructured":"Savvidis C, Ragia D, Kallistrou E, Kouroglou E, Tsiama V, Belis K, Ilias I, General H. Thyroxine Therapy. 2025;14:1\u201312. https:\/\/doi.org\/10.5492\/wjccm.v14.i3.102577.","journal-title":"Thyroxine Therapy"},{"key":"1130_CR48","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1111\/apt.17089","volume":"56","author":"S Lin","year":"2022","unstructured":"Lin S, Chanchlani N, Carbery I, Janjua M, Nice R, McDonald TJ, Bewshea C, Kennedy NA, Ahmad T, Selinger CP, et al. Understanding Anti-TNF Treatment Failure: Does Serum Triiodothyronine-to-Thyroxine (T3\/T4) Ratio Predict Therapeutic Outcome to Anti-TNF Therapies in Biologic-Na\u00efve Patients with Active Luminal Crohn\u2019s Disease? Aliment. Pharmacol Ther. 2022;56:783\u201393. https:\/\/doi.org\/10.1111\/apt.17089.","journal-title":"Pharmacol Ther"},{"key":"1130_CR49","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/nrrheum.2017.56","volume":"13","author":"V Ranganathan","year":"2017","unstructured":"Ranganathan V, Gracey E, Brown MA, Inman RD, Haroon N. Pathogenesis of Ankylosing Spondylitis-Recent Advances and Future Directions. Nat Rev Rheumatol. 2017;13:359\u201367. https:\/\/doi.org\/10.1038\/nrrheum.2017.56.","journal-title":"Nat Rev Rheumatol"},{"key":"1130_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/jcm14113677","volume":"14","author":"T Zormpa","year":"2025","unstructured":"Zormpa T, Thireou T, Beloukas A, Chaniotis D, Golfinopoulou R, Vlachakis D, Eliopoulos E, Papageorgiou L. The Genetic Background of Ankylosing Spondylitis Reveals a Distinct Overlap with Autoimmune Diseases: A Systematic Review. J Clin Med. 2025;14:1\u201333. https:\/\/doi.org\/10.3390\/jcm14113677.","journal-title":"J Clin Med"},{"key":"1130_CR51","doi-asserted-by":"crossref","unstructured":"Jang S, Kwon E, Lee JJ. Rheumatoid arthritis : pathogenic roles of diverse immune cells. 2022.","DOI":"10.3390\/ijms23020905"},{"key":"1130_CR52","doi-asserted-by":"publisher","first-page":"113709","DOI":"10.1016\/j.intimp.2024.113709","volume":"145","author":"Y Wei","year":"2025","unstructured":"Wei Y, Zhang S, Shao F, Sun Y. Ankylosing Spondylitis : From Pathogenesis to Therapy. Int Immunopharmacol. 2025;145:113709. https:\/\/doi.org\/10.1016\/j.intimp.2024.113709.","journal-title":"Int Immunopharmacol"},{"key":"1130_CR53","doi-asserted-by":"publisher","unstructured":"Mcinnes IB, Gravallese EM. Immune- \u200b mediated inflammatory disease therapeutics : past, present and future. Nat Rev Immunol. https:\/\/doi.org\/10.1038\/s41577-021-00603-1.","DOI":"10.1038\/s41577-021-00603-1"},{"key":"1130_CR54","doi-asserted-by":"crossref","unstructured":"Soh S, Uk M, Aw T. Laboratory testing in thyroid conditions \u2013 pitfalls and clinical utility. 2019;3\u201314.","DOI":"10.3343\/alm.2019.39.1.3"},{"key":"1130_CR55","doi-asserted-by":"crossref","unstructured":"Drobrzenski B, Carvalho GA. De challenges in thyroid function testing : interferences and clinical implications. 2023;1\u201313.","DOI":"10.18103\/mra.v11i8.4340"},{"key":"1130_CR56","doi-asserted-by":"publisher","unstructured":"Atzeni F, Talotta R, Salaf F, Cassinotti A, Varisco V, Battellino M, Ardizzone S, Pace F. Sarzi-puttini, P. Autoimmunity Reviews Immunogenicity and Autoimmunity during Anti-TNF Therapy. 2013;12:703\u20138, https:\/\/doi.org\/10.1016\/j.autrev.2012.10.021.","DOI":"10.1016\/j.autrev.2012.10.021"},{"key":"1130_CR57","doi-asserted-by":"publisher","unstructured":"Amouzegar A, Gharibzadeh S, Kazemian E, Mehran L, Tohidi M, Azizi F. The prevalence, incidence and natural course of positive antithyroperoxidase antibodies in a population-based study : tehran thyroid study. 2017;5:1\u201312. https:\/\/doi.org\/10.1371\/journal.pone.0169283.","DOI":"10.1371\/journal.pone.0169283"},{"key":"1130_CR58","doi-asserted-by":"crossref","unstructured":"Shiroky JB, Cohen M, Ballachey M, Neville C. Thyroid dysfunction in rheumatoid arthritis : a controlled prospective survey. 1993:454\u2013456.","DOI":"10.1136\/ard.52.6.454"},{"key":"1130_CR59","doi-asserted-by":"crossref","unstructured":"Rahmouni S, Dhifallah M, Mrad M, Bouall\u00e8gue E, Sahli H, Bahlous A. Prevalence and impact of thyroid dysfunction in patients with rheumatoid arthritis. 2025:1\u20139.","DOI":"10.1038\/s41598-025-13650-8"},{"key":"1130_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s41927-022-00293-9","volume":"9","author":"MB Fard","year":"2022","unstructured":"Fard MB, Yazdanifar MA, Aghaali M, Masoumi M. The prevalence of thyroid dysfunction and autoimmune thyroid disease in patients with rheumatoid arthritis. BMC Rheumatol. 2022;9:1\u20137. https:\/\/doi.org\/10.1186\/s41927-022-00293-9.","journal-title":"BMC Rheumatol"},{"key":"1130_CR61","doi-asserted-by":"publisher","unstructured":"Nazary K, Hussain N, Ojo RO, Anwar S, Kadurei F. Prevalence of thyroid dysfunction in newly diagnosed rheumatoid arthritis patients. 2021;13:2019\u201322. https:\/\/doi.org\/10.7759\/cureus.18204.","DOI":"10.7759\/cureus.18204"},{"key":"1130_CR62","doi-asserted-by":"publisher","unstructured":"Liu Y, Miao H, Lin S. Association between rheumatoid arthritis and thyroid dysfunction : a meta-analysis and systematic review. 2022:1\u201313, https:\/\/doi.org\/10.3389\/fendo.2022.1015516.","DOI":"10.3389\/fendo.2022.1015516"},{"key":"1130_CR63","doi-asserted-by":"crossref","unstructured":"Acay A, Ulu MS, Ahsen A, Eroglu S, Ozuguz U, Yuksel S. Assessment of thyroid disorders and autoimmunity in patients with rheumatic diseases. 2014:182\u2013186.","DOI":"10.2174\/1871530314666140626113111"}],"container-title":["BMC Pharmacology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40360-026-01130-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-026-01130-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-026-01130-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T16:48:15Z","timestamp":1779209295000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40360-026-01130-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,4]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1130"],"URL":"https:\/\/doi.org\/10.1186\/s40360-026-01130-2","relation":{"references":[{"id-type":"doi","id":"10.1016\/j.ando.2010.03.005","asserted-by":"subject"}]},"ISSN":["2050-6511"],"issn-type":[{"value":"2050-6511","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,4]]},"assertion":[{"value":"10 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Recep Tayyip Erdogan University Non-Invasive Clinical Research Ethics Committee (Approval Date: 08.02.2024; Approval Number: 2024\/35) and was conducted in accordance with the principles of the Declaration of Helsinki. Due to the retrospective nature of the study and the use of anonymized data obtained from existing medical records, the requirement for written informed consent was waived by the ethics committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Artificial intelligence-assisted technologies were utilized solely to enhance the readability and academic language of this manuscript during the writing process. After using this tool\/service, the authors reviewed and edited the content as needed and takes full responsibility for the content of the published article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Generative AI and AI-assisted technologies in the writing process"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"77"}}